Select Medical Holdings Corp (SEM, Financial) is set to release its Q3 2024 earnings on Oct 31, 2024. The consensus estimate for Q3 2024 revenue is $1.74 billion, and the earnings are expected to come in at $0.42 per share. The full year 2024's revenue is expected to be $7.03 billion and the earnings are expected to be $2.09 per share. More detailed estimate data can be found on the Forecast page.
Select Medical Holdings Corp (SEM, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Select Medical Holdings Corp (SEM) have increased from $6.98 billion to $7.03 billion for the full year 2024, and from $7.28 billion to $7.34 billion for 2025. Earnings estimates for the full year 2024 have remained stable at $2.09 per share, while estimates for 2025 have declined from $2.21 per share to $2.14 per share.
Select Medical Holdings Corp (SEM, Financial) Reported History
In the previous quarter of June 30, 2024, Select Medical Holdings Corp's (SEM) actual revenue was $1.76 billion, which beat analysts' revenue expectations of $1.74 billion by 0.87%. Select Medical Holdings Corp's (SEM) actual earnings were $0.60 per share, which missed analysts' earnings expectations of $0.62 per share by -2.44%. After releasing the results, Select Medical Holdings Corp (SEM) was down by -12.76% in one day.
Select Medical Holdings Corp (SEM, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 5 analysts, the average target price for Select Medical Holdings Corp (SEM) is $43.4 with a high estimate of $50 and a low estimate of $37. The average target implies an upside of 30.96% from the current price of $33.14.
Based on GuruFocus estimates, the estimated GF Value for Select Medical Holdings Corp (SEM, Financial) in one year is $31.35, suggesting a downside of -5.4% from the current price of $33.14.
Based on the consensus recommendation from 5 brokerage firms, Select Medical Holdings Corp's (SEM, Financial) average brokerage recommendation is currently 2.0, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
